US SB5206 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 25 2024 - 25% progression, died in committee
Action: 2024-09-25 - Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Pending: Senate Banking, Housing, And Urban Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 25 2024 - 25% progression, died in committee
Action: 2024-09-25 - Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Pending: Senate Banking, Housing, And Urban Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require a report on foreign investment in the pharmaceutical industry of the United States.
Title
United States Pharmaceutical Supply Chain Review Act
Sponsors
| Sen. Elizabeth Warren [D-MA] | Sen. Marco Rubio [R-FL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-09-25 | Senate | Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/5206/all-info |
| Text | https://www.congress.gov/118/bills/s5206/BILLS-118s5206is.pdf |
